Cancer News Genetics May Predict Bladder Cancer Immunotherapy Response Science Daily

Tiny implant wipes out bladder cancer in 82% of patients

TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, consistent release of chemotherapy proved far more effective than traditional ... Read More

New treatment eliminates bladder cancer in 82% of patients

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously ... Read More

Helping Patients Who Don’t Respond to Common Bladder Cancer Treatment

The bladder cancer treatment landscape is rapidly evolving, particularly for patients who don’t respond to bacillus Calmette–Guérin (BCG), the most common intravesical immunotherapy for early-stage ... Read More

New pretzel-shaped device cured 82% of bladder cancer patients — most in just 3 months

There’s a new twist in the fight against bladder cancer — and it’s delivering game-changing results. In a recent clinical trial, a pretzel-shaped device that slowly releases chemotherapy drugs ... Read More

A hormone that silences the immune system may unlock new cancer treatments

Scientists have discovered that cancer uses a hidden hormone to switch off the body’s natural defenses, allowing tumors to grow unchecked. By uncovering this secret signal, they found a way to block ... Read More

Are cancer surgeries removing the body’s secret weapon against cancer?

Scientists have found that preserving lymph nodes during cancer surgery could dramatically improve how patients respond to immunotherapy. The research shows that lymph nodes are essential for training ... Read More

Scientists just cracked the mystery of why cancer immunotherapy fails

Ohio State researchers have discovered that exhausted T cells collapse under the weight of misfolded proteins, activating a destructive stress response called TexPSR. Unlike normal stress systems, ... Read More

The Cancer Immunotherapy Revolution: From Artificial Sweeteners to T-Cell Monitoring

Immune checkpoint inhibitors, popularized by Allison and Honjo’s Nobel Prize, were one of the first cancer immunotherapies that gained FDA approval. In the 1990s, Allison and Honjo identified the ... Read More